UBS analyst Joseph Spak maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $107 to $99.
UBS Maintains Buy on Aptiv, Lowers Price Target to $99
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.